Triple therapy - Definitions, application, and treating to target

被引:8
作者
Davidson, MB [1 ]
机构
[1] King Drew Med Ctr, Diabet Program, Los Angeles, CA 90059 USA
关键词
D O I
10.2337/diacare.27.7.1834
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1834 / 1835
页数:2
相关论文
共 12 条
[1]   Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: A prospective, Randomized trial [J].
Aljabri, K ;
Kozak, SE ;
Thompson, DA .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (04) :230-235
[2]   Effect of nurse-directed diabetes care in a minority population [J].
Davidson, MB .
DIABETES CARE, 2003, 26 (08) :2281-2287
[3]   Improving efficacy of diabetes management using treatment algorithms in a mainly Hispani population [J].
Fanning, EL ;
Selwyn, B ;
Larme, AC ;
DeFronzo, RA .
DIABETES CARE, 2004, 27 (07) :1638-1646
[4]  
HSIA SH, 2004, DIABETES MELLITUS FU, P1177
[5]   GLYCOSYLATED HEMOGLOBIN AND THE RISK OF MICROALBUMINURIA IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
KROLEWSKI, AS ;
LAFFEL, LMB ;
KROLEWSKI, M ;
QUINN, M ;
WARRAM, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (19) :1251-1255
[6]   INTENSIVE INSULIN THERAPY PREVENTS THE PROGRESSION OF DIABETIC MICROVASCULAR COMPLICATIONS IN JAPANESE PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS - A RANDOMIZED PROSPECTIVE 6-YEAR STUDY [J].
OHKUBO, Y ;
KISHIKAWA, H ;
ARAKI, E ;
MIYATA, T ;
ISAMI, S ;
MOTOYOSHI, S ;
KOJIMA, Y ;
FURUYOSHI, N ;
SHICHIRI, M .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 28 (02) :103-117
[7]  
Pbulsen MKR, 2003, DIABETES CARE, V26, P3273
[8]   Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent - A systematic evaluation of triple oral therapy in a minority population [J].
Roy, R ;
Navar, M ;
Palomeno, G ;
Davidson, MB .
DIABETES CARE, 2004, 27 (07) :1741-1742
[9]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[10]   Improved glycemic weight control without gain using triple therapy in type 2 diabetes [J].
Strowig, SM ;
Avilés-Santa, ML ;
Raskin, P .
DIABETES CARE, 2004, 27 (07) :1577-1583